引用本文:上官士果.甘精胰岛素联合瑞格列奈治疗2型糖尿病的临床观察[J].中国临床新医学,2009,2(2):138-140.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1237次   下载 872 本文二维码信息
码上扫一扫!
分享到: 微信 更多
甘精胰岛素联合瑞格列奈治疗2型糖尿病的临床观察
上官士果
255311 淄博, 山东省生建八三医院内科
摘要:
[摘要] 目的 评价甘精胰岛素联合瑞格列奈治疗2型糖尿病的疗效和安全性。 方法 2007-06~2007-12对山东省生建八三医院所处社区的58例2型糖尿病患者应用甘精胰岛素联合瑞格列奈治疗,治疗前后测量空腹血糖(FBG),餐后2 h血糖(P2BG)、糖化血红蛋白(HbA1c)、体重及体重指数(BMI),观察低血糖发生率。结果 58例入选患者全部完成治疗观察。治疗24周后,患者的空腹血糖、餐后2 h血糖、糖化血红蛋白的平均值分别下降了2.17 mmol/L、3.26 mmol/L和1.45%,差异均有统计学意义(P<0.05);体重和体重指数略有增加, 但差异无统计学意义(P>0.05);低血糖发生率较低。 结论 甘精胰岛素联合瑞格列奈治疗2型糖尿病血糖控制效果好,低血糖发生率低,依从性良好。
关键词:  甘精胰岛素  瑞格列奈  2型糖尿病
DOI:
分类号:R 587.1
基金项目:
The clinical observation of insulin glargine combined with repaglinide in the treatment of type 2 diabetes mellitus
SHANGGUAN Shi-guo
Internal Medicine Department, the Shengjian 83 Hospital of Shandong Province, Zibo 255311, China
Abstract:
[Abstract] Objective To evaluate the curative effects and the security of insulin glargine combined with repaglinide in the treatment of type 2 diabetes mellitus.Methods Fifty-eight patients with type 2 diabetes mellitus from the community where shengjian 83 Hospital is located from June 2007 to December 2007 were treated by insulin glargine combined with repaglinide.The fasting blood glucose, 2 hours postpradial blood glucose, glycosylated hemoglobin, the body weight and the body weight index were measured, and the incidence of the hypoglycemia was observed.Results All the 58 patients being selected completed the treatment and the observation.After 24 weeks of the treatment, the mean values of fasting blood glucose, 2 hours postpradial blood glucose, glycosylated hemoglobin decreased by 2.17mmol/L, 3.26mmol/L and 1.45%respectively, the difference were statistically significant(P<0.05).The body weight and the body weight index slightly increased, but the difference were no statistionly significant. The incidence of hypoglycemia was lower. Conclusion The effects of blood glucose control of insulin glargine combined with repaglinide in the treatment of type 2 diabetes mellitus were good, the incidence of hypoglycemia is low and the compliance is good.
Key words:  Insulin glargine  Repaglinide  Type 2 diabetes mellitus